| abstract |
The present invention relates to a pharmaceutical composition containing at least one compatible solute and at least one antihistamine and / or a steroid, wherein the compatible solute is selected from the group consisting of: ectoine, 4,5,6,7-tetrahydro-2-methyl -1H- [1,3] -diazepine-4-S-carboxylic acid (homoectin), hydroxyectoine, di-myo-inositol phosphate (DIP), cyclic 2,3-diphosphoglycerate (cDPG), 1,1-di-glycerol phosphate (DGP ), β-mannosylglycerate (firoin), β-mannosylglyceramide (Firoin-A), di-mannosyl-di-inositol phosphate (DMIP), glucosylglycerol, taurine, betaine, citrulline and / or derivatives of these compounds such as salts, esters or acids. |